MHRA strengthens warnings on SSRIs, Effexor

The U.K.'s MHRA is requiring new labeling on SSRI depression drugs that strengthens warnings about

Read the full 159 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE